In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking

被引：0
|
作者：
Liang-qin Gao
Jing Xu
Shao-dong Chen
机构：
[1] Xiamen University,Department of Traditional Chinese Medicine, Xiamen University Hospital
[2] Xiamen University,College of Ocean and Earth Sciences
[3] Xiamen University,Department of Traditional Chinese Medicine, School of Medicine
来源：
Chinese Journal of Integrative Medicine | 2020年 / 26卷
关键词：
molecular docking; COVID-19; SARS-CoV-2 3CL hydrolytic enzyme; angiotensin converting enzyme II; Chinese medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：527 / 532
页数：5
相关论文
共 50 条
  • [41] Prospecting for Cressa cretica to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2
    Shah, Sapan
    Chaple, Dinesh
    Arora, Sumit
    Yende, Subhash
    Mehta, Chetan
    Nayak, Usha
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (12): : 5643 - 5652
  • [42] Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent
    Basit, Abdul
    Ali, Tanveer
    Rehman, Shafiq Ur
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (10): : 3605 - 3614
  • [43] Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2
    Alsibai, Kinan Drak
    MEDICAL HYPOTHESES, 2020, 143
  • [44] Molecular Basis for Antiviral Action of EDP-235: A Potent and Selective SARS-CoV-2 3CLpro Inhibitor for the Treatment of Covid 19
    Balakrishnan, Anand
    Reyes, Archie
    Shen, Ruichao
    Bisht, Nalini
    Sweeney, Joyce
    Levene, Rachel
    McAllister, Nicole
    Cressey, Tessa
    Manalo, Nathan
    Rhodin, Michael H.
    Vaine, Michael
    Wang, Guoqiang
    Orryan, Yat Sun
    Goodwin, Bryan
    FASEB JOURNAL, 2022, 36
  • [45] Virtual screening and molecular dynamics simulation to identify potential SARS-CoV-2 3CLpro inhibitors from a natural product compounds library
    Gan, Chunchun
    Jia, Xiaopu
    Fan, Shuai
    Wang, Shuqing
    Jing, Weikai
    Wei, Xiaopeng
    ACTA VIROLOGICA, 2023, 67
  • [46] Identification of doxorubicin as a potential therapeutic against SARS-CoV-2 (COVID-19) protease: a molecular docking and dynamics simulation studies
    Sajid Jamal, Qazi Mohammad
    Alharbi, Ali H.
    Ahmad, Varish
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (17): : 7960 - 7974
  • [47] The identification of novel inhibitors of human angiotensin-converting enzyme 2 and main protease of Sars-Cov-2: A combination of in silico methods for treatment of COVID-19
    Zarezade, Vahid
    Rezaei, Hamzeh
    Shakerinezhad, Ghodratollah
    Safavi, Arman
    Nazeri, Zahra
    Veisi, Ali
    Azadbakht, Omid
    Hatami, Mahdi
    Sabaghan, Mohamad
    Shajirat, Zeinab
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1237
  • [48] Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak
    Mohammad Mahfuz Ali Khan Shawan
    Sajal Kumar Halder
    Md. Ashraful Hasan
    Bulletin of the National Research Centre, 45 (1)
  • [49] Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic
    Muteeb, Ghazala
    Alshoaibi, Adil
    Aatif, Mohammad
    Rehman, Md. Tabish
    Qayyum, M. Zuhaib
    APPLIED BIOLOGICAL CHEMISTRY, 2020, 63 (01)
  • [50] Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic
    Ghazala Muteeb
    Adil Alshoaibi
    Mohammad Aatif
    Md. Tabish Rehman
    M. Zuhaib Qayyum
    Applied Biological Chemistry, 2020, 63
12345